from: Boshoff et al (2004). The transcriptional responses of Mycobacterium tuberculosis to inhibitors of metabolism. J Biol Chem.

Gene Expression Profile for Rv0429c/def

LFCtreatmentdescriptionclass of inhibitor

0.521

Amikacinug/mL Amikacintranslation

0.987

Cap5-10ug/mL Capreomycintranslation

1.033

Rox10-50 ug/mL Roxithromycintranslation

0.417

SM2-5 ug/mL Streptomycintranslation

0.277

Tet5-10 ug/mL Tetracyclinetranslation

-0.081

Rif0.2-5ug/mL Rifampicintranscription

-0.392

Rifp0.1-0.5ug/mL Rifapentinetranscription

-0.143

Min_med__succinate_Minimal medium with succinate as sole carbon source as compared to growth in 7H9/ADC/Tween/glycerolstarvation

-3.000

CCCP10-50 uM Carbonyl cyanide 3-chlorophenylhydrazonerespiration

-0.542

CPZ10-50 ug/mL Chlorpromazinerespiration

-1.005

Clofazimine10-13 ug/mL Clofaziminerespiration

0.126

Clotrimazole10-24 ug/mL Clotrimazole (azole drug)respiration

-0.944

DCCD20-100 uM Dicyclohexylcarbodiimiderespiration

-1.900

DNP"0.5-2.5 mM 2,4-Dinitrophenol"respiration

-1.760

DTT"1-2 mM 1,4-Dithio-DL-threitol"respiration

-0.173

Econazole10-24 ug/mL Econazole (azole drug)respiration

-1.055

GSNO_CFZ0.1 mM S-Nitrosoglutathione + 5 ug/mL Clofaziminerespiration

-0.852

GSNO_CPZ0.1 mM S-Nitrosoglutathione + 20-25 ug/mL Chlorpromazinerespiration

-0.960

GSNO_KCN0.1mM S-Nitrosoglutathione + 5ug/mL potassium cyaniderespiration

0.056

GSNO_menadione0.1 mM S-Nitrosoglutathione + 6-10 ug/mL menadionerespiration

-1.912

KCN5-20 ug/mL Potassium cyaniderespiration

-0.273

NaN30.2-2 mM Sodium aziderespiration

1.421

Nigericin50 uM Nigericinrespiration

-0.842

TRC10-150 ug/mL Triclosanrespiration

-1.289

TRZ10-25 ug/mL Thioridazinerespiration

-1.425

Valinomycin0.5-10 uM Valinomycinrespiration

0.953

ZnSO42 mM ZnSO4respiration

-0.347

menadione6-10 ug/mL Menadionerespiration

0.115

Ascididemin_Nat_prod4-9 ug/mL Organic extract of Eudistoma amplumironLimitation

0.907

Deferoxamine150-250 uM Deferoxamine mesylateironLimitation

-0.208

Dipyridyl"100-200 uM 2,2'-Bipyridyl"ironLimitation

1.237

GSNO0.02-0.1mM S-NitrosoglutathionedosRassociated

0.292

NRP_1Non-replicating persistence stage 1dosRassociated

0.529

Amp0.2mg/mL AmpicillincellWall

0.673

Cephalexin20-100 ug/mL CephalexincellWall

1.310

Cerulenin0.32-5 ug/mL CerulenincellWall

0.445

DIPED5-100 ug/mL DiisopropylethylenediaminecellWall

0.511

EMB10-20 ug/mL EthambutolcellWall

0.722

Eta12-40 ug/mL EthionamidecellWall

0.962

INH0.2-0.4 ug/mL IsoniazidcellWall

0.466

TLM0.1-0.2 mg/mL ThiolactomycincellWall

0.399

PalmitateMinimal medium with palmitate as sole C-source as compared to minimal medium with glucose as sole CsourcecarbonSource

1.020

SuccinateMinimal medium with succinate as sole C-source as compared to minimal medium with glucose as sole CsourcecarbonSource

-0.545

BZA0.12 mg/mL BenzamidearomaticAmides

-0.413

Nam0.12 - 1.2 mg/mL NicotinamidearomaticAmides

-0.140

PZA0.12-1.2 mg/mL PyrazinamidearomaticAmides

0.058

H2O24 mM hydrogen peroxideDNAdamaging

0.897

Levo10 ug/mL LevofloxacinDNAdamaging

0.423

Mtm0.1-0.2 ug/mL Mitomycin CDNAdamaging

0.458

Novobiocin10 ug/mL NovobiocinDNAdamaging

1.421

Oflox5-10 ug/mL OfloxacinDNAdamaging

0.814

UVUV-irradiationDNAdamaging

-1.663

ARP41-4 ug/mL Antitubercular compound ARP4?

0.616

Antimycin12.5-50 ug/mL Antimycin A?

1.091

DTNB"1-2 mM 5,5'-Dithiobis(2-nitrobenzoic acid)"?

0.253

PA_110-50 ug/mL Antitubercular compound PA-1?

0.131

PA_2110-50 ug/mL Antitubercular compound PA-21?

-1.138

PA8240.2-2 ug/mL PA-824?

-0.673

Procept_677620-30 ug/mL Antitubercular compound Procept 6776?

0.240

Procept_67785-40 ug/mL Antitubercular compound Procept 6778?

0.694

Verapamil50 uM Verapamil?

0.844

mercaptoethanol2 mM 2-Mercaptoethanol?

1.238

methoxatin10-20 ug/mL Methoxatin?